Qube Research & Technologies LTD Clear Point Neuro, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 51,789 shares of CLPT stock, worth $590,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,789Holding current value
$590,912% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding CLPT
# of Institutions
89Shares Held
7.14MCall Options Held
35KPut Options Held
22.8K-
Vanguard Group Inc Valley Forge, PA1.22MShares$13.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny465KShares$5.31 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$5.29 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$4.28 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.18 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $279M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...